Tower Capital Group
Tower Capital Group is a private investment firm that pioneered the Generational Health category, operating invitation-only funds and curated programs that connect qualified investors and family offices with innovators in longevity, women's health, regenerative medicine, and Bio AI.
- Company typePrivate
- Founded2021
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Tower Capital Group does
Tower Capital Group LLC, founded in 2021 and headquartered at 57 West 57th Street, New York, is a privately held investment and economic development firm that pioneered and defined the "Generational Health" investment category — health effects transmitted genetically, epigenetically, and environmentally across multiple generations. Founder, Executive Officer & Chairwoman Sanskriti Thakur and President & Managing Partner Vani Rao lead a global team spanning five continents, with combined operating experience that includes prior roles at Medable, Accenture, Boehringer Ingelheim, RockHealth, and Jefferson University Hospitals. The firm operates three coordinated entities covering research, development, and funding, with the TOWER Council Foundation (launched December 2023) acting as an independent non-profit affiliate for research and education.
TOWER's core offerings include the TOWER Generations Program (curated invitation-only access to Generational Health innovators in Bio AI, longevity, regenerative medicine, women's health, and human health systems), TOWER HQ as a physical Generational Health Hub in NYC with planned Dallas and Seattle hubs, a published $17.4B Generational Health market assessment covering 400+ entities across 8 industry sectors and 14 industry groups, and multiple specialized investment vehicles including the Infinity Fund (launched September 2025 with Aurion Capital and Terran Capital Group as the first global Generational Health fund), the Generational Food Systems Fund, the Generational Sports Fund, and the M2 Generational Health Options Fund. Underlying these is a proprietary Impact and Growth Scoring methodology that classifies entities by scientific effect (reproductive, developmental, genetic/epigenetic) and evaluates them across five scored categories.
Revenue is generated through fund management (Infinity Fund and other vehicles), curated investment management for qualified investors and family offices, and economic development/professional services to governments and corporations. Distribution is exclusively private and invitation-only, anchored by TOWER HQ, quarterly symposiums, journalist-moderated founder interviews, and high-profile events at Davos (WEF Key Partner since 2024) and UNGA (UNFPA partnership since 2025). Strategic partners include WEF, UNFPA, Davos Alzheimer's Collaborative, HekaBio (Japan/APAC), Uncharted Pitches, GCWC Capital, Aurion Capital, Terran Capital Group, Springboard Enterprises, and the Equalizer/UNFPA Accelerator Fund.
Tower Capital Group firmographics
Firmographics- Name
- Tower Capital Group
- Legal name
- Tower Capital Group LLC
- Website
- https://towercapital.org
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Tower Capital Group is a private investment firm that pioneered the Generational Health category, operating invitation-only funds and curated programs that connect qualified investors and family offices with innovators in longevity, women's health, regenerative medicine, and Bio AI.
- Ownership category
- akta.pro rank
Tower Capital Group industry classification
Industry- Product category
- Alternative Investments / Impact Investment Management
- NAICS
- Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
- akta.pro secondary industries
- Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest) (FSAAADAH), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Tower Capital Group is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Tower Capital Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- Investment Management: TOWER operates funding platforms for premium financial investments in Generational Health markets. The company manages collaborative funding vehicles focused on Generational Health components.
- Fund Management: Manages Generational Health investment funds including Infinity Fund (first global fund backing leading Generational Innovators), Generational Food Systems Fund, Generational Sports Fund, and M2 Generational Health Options Fund.
- Market Development Services: Economic development services to governments, corporations and private entities for deploying capital into Generational Health entities to improve societal outcomes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Qualified Investors Only - Private Investment Access |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Tower Capital Group product offering
Product offeringCore offering
TOWER Capital Group is the published pioneer of Generational Health, operating through three entities (research, development, and funding) to grow the economies of Generational Health globally. The firm curates and evaluates 400+ Generational Health entities representing $17.4B in invested capital, granting qualified investors private access to specialized investment opportunities through the TOWER Generations Program and dedicated funds including the Infinity Fund, Generational Sports Fund, Generational Food Systems Fund, and M2 Generational Health Options Fund.
Product overview
TOWER Capital Group is the global pioneer of Generational Health, operating a multi-vector strategy through three affiliated entities: research/definition, development, and funding. The core offerings include the TOWER Generations Program (investment access to curated Generational Health innovators), TOWER HQ (the first Generational Health Hub in NYC), the TOWER Council Foundation (non-profit research and education), and multiple specialized investment funds including the Infinity Fund (first global Generational Health fund), Generational Foods Fund, Generational Sports Fund, and M2 Options Fund. The company also publishes market research including the landmark $17.4B Generational Health market assessment. TOWER connects innovators in Bio AI, longevity, regenerative medicine, women's health, and human health systems with qualified investors through private sessions and ecosystem events.
Differentiator
Problem solved
Functional benefit
Products and services
- TOWER Generations Program Invitation-only investment program delivering private access to world-leading Generational Health innovators for qualified investors, featuring journalist-moderated founder conversations, confidential company updates, and introductions to edge-case companies in Bio AI, longevity, regenerative medicine, women's health, and human health systems.
- TOWER HQ (Generational Health Hub) The first physical space dedicated to Generational Health, located at 57 West 57th Street, New York. Headquarters for 50+ global experts, US and national partners, and curated global ecosystem, featuring showcases of GH innovators and quarterly symposiums on scientific and technological research topics.
- Infinity Fund The first global fund backing leading Generational Health innovators, launched in partnership with Aurion Capital and Terran Capital Group to shape durable Generational Health markets.
- Generational Sports Fund Specialized investment strategy focused on sport health and performance longevity innovations, led by Partner Mark Sadovnick and convening capital around next-generation sports technology and human capital.
- TOWER X M2 Generational Health Options Fund The first global secondaries options fund offered in the Generational Health category, designed for limited participation by qualified investors.
- Generational Health Market Assessment Report First-in-kind assessment of $17.4B USD in Generational Health entities by total funding raised, demonstrating TOWER's investment thesis across 8 industry sectors and 14 industry groups.
- Women's Health responsible investment (WHRI) consortium First-in-kind global consortium launched in partnership with the World Economic Forum, dedicated to funding women's health as a generational health imperative through responsible investment.
- Generational Health Market Development Services Economic development and advisory services provided to governments, corporations, and private entities for deploying capital into Generational Health entities to improve societal outcomes.
Quantifiable outcome
- $28B USD in Generational Health assets evaluated and published
- +5 more outcomes
Companies that use Tower Capital Group
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Tower Capital Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
Tower Capital Group partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered major, core and minor.
- GCWC CapitalmajorGCWC Capital in partnership with TOWER to launch a fund focused on visionary builders of AI-native solutions that will reshape the future of healthcare and financial services. TOWER HQ serves as venue for private introduction to investment strategy.
- HekaBiocoreTower Capital Group and HekaBio entered commercial partnership to expand Generational Health access in Japan and Asia-Pacific. HekaBio scales healthcare commercialization by licensing and scaling innovative pharma, diagnostics, and MedTech assets across Japan and APAC markets. Already 8 assets in progress with measurable revenues.
- UNFPA (United Nations Population Fund)coreTOWER partnered with UNFPA at UNGA 80th session to bridge the gap between breakthrough solutions, capital, partnerships, and political will to scale what works. UNFPA's Equalizer: UNFPA Accelerator Fund has been catalyzing innovation since 2021 for women's health, gender equality, and youth empowerment.
- World Economic Forum (WEF)coreTOWER Capital Group was named a key partner by WEF at Davos 2024. TOWER committed to advancing women's health and bringing awareness to the role of women in Generational Health. TOWER presented at Davos 2024 and is partnered with WEF to launch the Global Women's Health responsible investment (WHRI) consortium.
- Davos Alzheimer's CollaborativecoreTOWER and Davos Alzheimer's Collaborative share a mission to support long-term outcomes in healthcare's most challenging areas particularly those with multigenerational impacts. Partnership advancing solutions that strengthen brain health, reducing the impact of Alzheimer's, and improving lives of individuals, families, and communities worldwide.
- Uncharted PitchescoreTOWER partnered with Uncharted Pitches for the Generations Program, bringing Generational Solutions to Families. Uncharted is an invite-only community at intersection of entrepreneurship, venture and influence. Partnership breaks down barriers for investors to access life science deal flow through journalist-led founder interviews.
- Springboard EnterprisesminorTOWER partnered with Springboard Enterprises for MEET THE NEW CEO event as part of UNGA discussions around Generational Health leadership.
- TOWER Council FoundationcoreTOWER Council is an independent non-profit group launched December 2023, led by President Vani Rao, poised to lead the way in groundbreaking research and provision of educational resources supporting charitable action in Generational Health space.
Scale indicators9 records
Recent moves8 records
Expansion highlights5 records
Tower Capital Group competitors and assessment
Company assessmentDirect peers
- RA Capital Management: Healthcare and life-sciences-focused investment firm operating multiple funds across public and private markets. Directly comparable as a sector-specialist manager building thematic portfolios in health innovation.
- Venrock: Venture capital firm with deep healthcare and technology portfolios. Comparable as a long-standing healthcare-focused investor with thesis-driven fund construction.
- OrbiMed Advisors: Healthcare-dedicated investment firm spanning venture, growth, public equity, and royalty. Comparable as a full-spectrum healthcare investor with thematic fund structures.
- ARCH Venture Partners: Venture capital firm focused on founding and building life sciences and technology companies from earliest stages. Comparable as a science-led investor that creates and funds new health categories.
- Flagship Pioneering: Bioplatform innovation company that originates and grows breakthrough life sciences ventures. Closely comparable to TOWER's category-creation model in defining new health investment frameworks.
- Section32: Venture fund investing at the intersection of technology and healthcare, with a category-creation orientation. Comparable for its science-driven, frontier health investment thesis.
- RockHealth: Digital health venture fund and advisory platform. Comparable as a digital-health investment specialist; TOWER advisor Tom Cassels is a former RockHealth CEO, evidencing direct relationship.
- Lux Capital: Venture firm investing in emerging science and technology ventures, including health and biology. Comparable for its frontier-science orientation and thesis-driven category investment.
Broad incumbents
- Khosla Ventures: Sector-focused venture firm investing across deep tech, health, and sustainability. Comparable for its thematic, science-forward investment approach, though broader in mandate than TOWER.
- Andreessen Horowitz (a16z Bio): Large multi-stage venture firm operating a dedicated Bio fund that invests across healthcare and life sciences. Comparable for its broad life-sciences investing platform, though part of a wider tech portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Tower Capital Group social profiles
Digital presenceTower Capital Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tower Capital Group leadership team
Management profileNumber of profiles
Profiles11 records
Tower Capital Group subsidiaries and ownership
Company hierarchySubsidiaries3 records
Tower Capital Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tower Capital Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tower Capital Group
What does Tower Capital Group do?
TOWER Capital Group is the published pioneer of Generational Health, operating through three entities (research, development, and funding) to grow the economies of Generational Health globally. The firm curates and evaluates 400+ Generational Health entities representing $17.4B in invested capital, granting qualified investors private access to specialized investment opportunities through the TOWER Generations Program and dedicated funds including the Infinity Fund, Generational Sports Fund, Generational Food Systems Fund, and M2 Generational Health Options Fund.
Is Tower Capital Group a public or private company?
Tower Capital Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Tower Capital Group founded?
Tower Capital Group was founded in 2021. It employs 11 to 50 people.
Where is Tower Capital Group based?
Tower Capital Group is headquartered in New York, United States, in the North America region.
How does Tower Capital Group make money?
Three revenue lines are on record. Investment Management is the primary driver. The others are fund Management and market Development Services.
Who are Tower Capital Group's main competitors?
Direct peers on record are RA Capital Management, Venrock, OrbiMed Advisors, ARCH Venture Partners, Flagship Pioneering, Section32, RockHealth and Lux Capital. Broad incumbents are Khosla Ventures and Andreessen Horowitz (a16z Bio).
Does Tower Capital Group have an API?
No public API is recorded for Tower Capital Group.
What industry is Tower Capital Group in?
Tower Capital Group's product category is Alternative Investments / Impact Investment Management. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSAAADAH, Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest). Its NAICS code is 523940 and its SIC code is 6282.